Medico Intercontinental Share Price Today

Medico Intercontinental Q2FY27 Results: Standalone net profit up 3% to ₹60.84 lakh

Standalone net profit rose 2.8% YoY to ₹60.84 lakh in Q2FY27. Standalone revenue from operations increased 13.9% YoY to ₹1,414.06 lakh. Consolidated net profit turned positive at ₹4.42 lakh vs loss of ₹450.70 lakh in Q2FY26. Consolidated revenue grew 12% YoY to ₹2,284.53 lakh. Standalone operating cash flow turned negative at ₹231.72 lakh for H1FY27.

Medico Intercontinental 42nd AGM passes all 7 resolutions

All 7 resolutions at Medico Intercontinental's 42nd AGM on September 30, 2026 were passed with requisite majority. Resolutions 1 and 2 saw 6,767,024 valid votes polled, with 99.99% in favour and 0.01% against. Resolutions 3 to 7 covering related party transactions with Oxford Pharma, LYF Distributor, Medico Lab, Calborn Lifescience Private Limited, and Samir D Shah each recorded 915,628 valid votes with 99.90% in favour. Promoter votes totalling 5,851,396 shares were treated as invalid for related party transaction resolutions due to promoter interest. 25 members attended the AGM via video conferencing; total shareholders on record date stood at 4,040.

Medico Intercontinental schedules AGM for September 30, 2026

Medico Intercontinental schedules AGM for September 30, 2026. Meeting will be held via VC/OAVM at 2:00 pm. Book closure runs from September 24 to September 30, 2026. Record date for e-voting is set for September 23, 2026.

Medico Intercontinental Q1 Results: Standalone profit rises 9% YoY to ₹60.8 lakh

Medico Intercontinental Limited reported Q1FY27 standalone net profit of ₹60.76 lakh, up 9% YoY. Consolidated results showed a net loss of ₹404.23 lakh on revenue of ₹2,084 lakh. The divergence highlights operational challenges within group subsidiaries.

Medico Intercontinental promoter acquires 1.36 lakh shares

Medico Intercontinental Limited disclosed that its Promoter and Managing Director, Samir Dilipkumar Shah, acquired 1,36,886 equity shares through open market purchases between June 3 and June 24, 2026. This increased his stake to 47,76,999 shares, representing 47.77% of the company's share capital. The transactions were executed on the BSE and disclosed in compliance with SEBI regulations.

Medico Intercontinental FY26 net profit falls 15%

Medico Intercontinental reported a decline in standalone net profit to ₹218.36 lakh for FY26, down from ₹256.58 lakh in the previous year, while consolidated results shifted to a net loss of ₹1098.04 lakh. For the quarter ended March 31, 2026, standalone net profit was ₹42.41 lakh, and the consolidated net loss was ₹233.25 lakh. Additionally, the Board re-appointed M/s. MJV & Co as Internal Auditor for FY27.